Ac­tivist in­vestor push­es Bay­er to sep­a­rate crop sci­ence, con­sumer health from phar­ma

An ac­tivist in­vestor is urg­ing Bay­er to split its three main units and shake up the su­per­vi­so­ry board as share­hold­ers are set to meet for their an­nu­al con­fab next week and Bill An­der­son pre­pares to take over as CEO in June.

Blue­bell Cap­i­tal Part­ners is call­ing on the Ger­man con­glom­er­ate to split its phar­ma and crop sci­ence units in ad­di­tion to ex­it­ing con­sumer health, much like what sev­er­al oth­er phar­ma com­pa­nies have done in re­cent years. The Lon­don-based firm al­so calls for the four su­per­vi­so­ry board mem­bers whose terms end next year to be re­placed by in­de­pen­dent can­di­dates.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER